Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001615219-25-000059
Filing Date
2025-05-27
Accepted
2025-05-27 09:30:48
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A salarius-defa14a2025proxyn.htm DEFA14A 17501
2 a1screenshot2025-05x261925.jpg GRAPHIC 435410
3 a2screenshot2025-05x261926.jpg GRAPHIC 346193
4 a3screenshot2025-05x261927.jpg GRAPHIC 281538
5 a4screenshot2025-05x261928.jpg GRAPHIC 239613
  Complete submission text file 0001615219-25-000059.txt   1813313
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36812 | Film No.: 25984799
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)